Valneva SE (VALN) Gross Profit (2021 - 2026)
Valneva SE (VALN) reported Gross Profit of $5.1 million for Q1 2026, down 81.11% on a YoY basis from $26.9 million in Q1 2025, and up 79.58% sequentially from $2.8 million in Q4 2025.
Valneva SE (VALN) Gross Profit (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of Gross Profit data on file, last reported at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit fell 81.11% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $33.9 million (down 60.67% YoY), and the FY2025 full-year result was $59.1 million, down 15.7% from the prior year.
- Gross Profit improved to $5.1 million in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $168.5 million in Q4 2022 to a low of -$149.9 million in Q2 2022.
- A 5-year average of $12.9 million and a median of $12.5 million in 2023 frame the typical range for Gross Profit.
- Peak annual rise in Gross Profit reached 1461.53% in 2022, while the deepest fall reached 2671.57% in 2022.
- Tracing VALN's Gross Profit over 5 years: stood at $168.5 million in 2022, then plunged by 86.26% to $23.2 million in 2023, then grew by 8.78% to $25.2 million in 2024, then plunged by 88.77% to $2.8 million in 2025, then soared by 79.58% to $5.1 million in 2026.
- Business Quant data shows VALN's Gross Profit at $5.1 million in Q1 2026, $2.8 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Mar 31, 2025 | 26.88 Mn |
| Mar 31, 2025 | 26.88 Mn |
| Dec 31, 2024 | 25.18 Mn |
| Dec 31, 2024 | 25.18 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Jun 30, 2024 | 13.64 Mn |
| Jun 30, 2024 | 13.64 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Dec 31, 2023 | 23.15 Mn |
| Dec 31, 2023 | 23.15 Mn |